VeriChip Corporation announces changes to Board of Directors to remove all overlap with Digital Angel
VeriChip Corporation, a provider of RFID systems for healthcare and patient-related needs, today announced a series of changes to its Board of Directors to remove all overlap between its Board and Digital Angel's Board.
VeriChip Corporation and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN™ chemistry platform can be applied to the development of selective binding products, announced today they will host an event for the medical, patient and investor communities on October 22, 2009, in New York to unveil details of their virus triage detection system for the H1N1 virus and Phase II development of an in vivo glucose-sensing RFID microchip.